Sulzer to sell its $323 million electrophysiology business
This article was originally published in Clinica
Executive Summary
Sulzer Medica is to divest its electrophysiology business, which, at $323 million, represents one-third of Sulzer's Medica total sales, to concentrate on its orthopaedics and cardiovascular prostheses businesses. Both Sulzer Medica and parent company Sulzer's shares hit a year's high on the news.